MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
4.780
-0.060
-1.24%
After Hours: 4.870 +0.09 +1.88% 16:35 08/13 EDT
OPEN
4.800
PREV CLOSE
4.840
HIGH
4.870
LOW
4.700
VOLUME
121.22K
TURNOVER
--
52 WEEK HIGH
5.73
52 WEEK LOW
3.060
MARKET CAP
91.65M
P/E (TTM)
-2.5009
1D
5D
1M
3M
1Y
5Y
1D
PolyPid Earnings Call: Priority Review, Big Azurity Deal
TipRanks · 22h ago
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
TipRanks · 1d ago
PolyPid Advances D-PLEX100; FDA Grants Priority Review
NASDAQ · 1d ago
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)
TipRanks · 1d ago
PolyPid Wins FDA Priority Review for D-PLEX₁₀₀ and Locks In $30 Million Azurity Milestones
TipRanks · 1d ago
PolyPid Q2 EPS $(0.35) Beats $(0.38) Estimate
Benzinga · 1d ago
Weekly Report: what happened at PYPD last week (0803-0807)?
Weekly Report · 3d ago
Weekly Report: what happened at PYPD last week (0727-0731)?
Weekly Report · 08/03 09:51
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.